Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase 2
- Conditions
- Colorectal Cancer
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 225
- Registration Number
- NCT00625625
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
Not Applicable
Completed
- Conditions
- Melanoma
- Interventions
- Procedure: Monitoring with nodal ultrasoundProcedure: Completion Lymphadenectomy
- First Posted Date
- 2006-03-01
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 1939
- Registration Number
- NCT00297895
- Locations
- 🇺🇸
St. Luke's Hospital, Bethlehem, Pennsylvania, United States
🇺🇸Buffalo General Hospital, Buffalo, New York, United States
🇺🇸Mercy Medical Center, Baltimore, Maryland, United States
Multicenter Selective Lymphadenectomy Trial (MSLT)
Phase 3
Completed
- Conditions
- Melanoma
- Interventions
- Procedure: Sentinel Lymph Node DissectionProcedure: Wide ExcisionProcedure: Complete Lymph Node Dissection
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 2001
- Registration Number
- NCT00275496
© Copyright 2025. All Rights Reserved by MedPath